Recent studies have shown that TACSTD2 has a critical role in the metastasis of prostate cancers by modulating β1 integrin function, and activation of PAK4 induced by TACSTD2 was observed in the experiment (24,25). Here, PAK4 is linked to prostate carcinoma.